ENDRA regains Nasdaq equity compliance after $4.9M offering; adds crypto treasury

ENDRA Life Sciences Inc.

Closed Oct 2025 private placement raising ~$4.9M gross via 744,340 shares and warrants.
Purchased 78,863.1 HYPE tokens on Oct 23, 2025 under new digital asset treasury strategy.
Entered ATM sales agreement with Lucid Capital Markets for up to $1.75M in common stock.
Nasdaq granted extension to Nov 24, 2025; company now believes it meets $2.5M equity minimum.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.